157 related articles for article (PubMed ID: 38295320)
41. Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
Yang Q; Tian Y; Ostler KR; Chlenski A; Guerrero LJ; Salwen HR; Godley LA; Cohn SL
BMC Cancer; 2010 Jun; 10():286. PubMed ID: 20546602
[TBL] [Abstract][Full Text] [Related]
42. Whole-genome analysis of 5-hydroxymethylcytosine and 5-methylcytosine at base resolution in the human brain.
Wen L; Li X; Yan L; Tan Y; Li R; Zhao Y; Wang Y; Xie J; Zhang Y; Song C; Yu M; Liu X; Zhu P; Li X; Hou Y; Guo H; Wu X; He C; Li R; Tang F; Qiao J
Genome Biol; 2014 Mar; 15(3):R49. PubMed ID: 24594098
[TBL] [Abstract][Full Text] [Related]
43. Quantitative assessment of copy number alterations by liquid biopsy for neuroblastoma.
Shirai R; Osumi T; Sato-Otsubo A; Nakabayashi K; Ishiwata K; Yamada Y; Yoshida M; Yoshida K; Shioda Y; Kiyotani C; Terashima K; Tomizawa D; Takasugi N; Takita J; Miyazaki O; Kiyokawa N; Yoneda A; Kanamori Y; Hishiki T; Matsumoto K; Hata K; Yoshioka T; Kato M
Genes Chromosomes Cancer; 2022 Nov; 61(11):662-669. PubMed ID: 35655408
[TBL] [Abstract][Full Text] [Related]
44. Loss of 5-Hydroxymethylcytosine Is an Epigenetic Biomarker in Cutaneous T-Cell Lymphoma.
Qiu L; Liu F; Yi S; Li X; Liu X; Xiao C; Lian CG; Tu P; Wang Y
J Invest Dermatol; 2018 Nov; 138(11):2388-2397. PubMed ID: 29803640
[TBL] [Abstract][Full Text] [Related]
45. Genome-wide positioning of bivalent mononucleosomes.
Sen S; Block KF; Pasini A; Baylin SB; Easwaran H
BMC Med Genomics; 2016 Sep; 9(1):60. PubMed ID: 27634286
[TBL] [Abstract][Full Text] [Related]
46. Cell-Free DNA 5-Hydroxymethylcytosine Signatures for Lung Cancer Prognosis.
Shao J; Olsen RJ; Kasparian S; He C; Bernicker EH; Li Z
Cells; 2024 Feb; 13(4):. PubMed ID: 38391911
[TBL] [Abstract][Full Text] [Related]
47. Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma.
Lodrini M; Graef J; Thole-Kliesch TM; Astrahantseff K; Sprüssel A; Grimaldi M; Peitz C; Linke RB; Hollander JF; Lankes E; Künkele A; Oevermann L; Schwabe G; Fuchs J; Szymansky A; Schulte JH; Hundsdörfer P; Eckert C; Amthauer H; Eggert A; Deubzer HE
Clin Cancer Res; 2022 May; 28(9):1809-1820. PubMed ID: 35247920
[TBL] [Abstract][Full Text] [Related]
48. TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma.
Mariani CJ; Vasanthakumar A; Madzo J; Yesilkanal A; Bhagat T; Yu Y; Bhattacharyya S; Wenger RH; Cohn SL; Nanduri J; Verma A; Prabhakar NR; Godley LA
Cell Rep; 2014 Jun; 7(5):1343-1352. PubMed ID: 24835990
[TBL] [Abstract][Full Text] [Related]
49. High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.
Kujala J; Hartikainen JM; Tengström M; Sironen R; Kosma VM; Mannermaa A
Cancer Med; 2020 Aug; 9(16):5922-5931. PubMed ID: 32602248
[TBL] [Abstract][Full Text] [Related]
50. Decrease of 5hmC in gastric cancers is associated with TET1 silencing due to with DNA methylation and bivalent histone marks at TET1 CpG island 3'-shore.
Park JL; Kim HJ; Seo EH; Kwon OH; Lim B; Kim M; Kim SY; Song KS; Kang GH; Kim HJ; Choi BY; Kim YS
Oncotarget; 2015 Nov; 6(35):37647-62. PubMed ID: 26462176
[TBL] [Abstract][Full Text] [Related]
51. MYCN and PRC1 cooperatively repress docosahexaenoic acid synthesis in neuroblastoma via ELOVL2.
Ding Y; Yang J; Ma Y; Yao T; Chen X; Ge S; Wang L; Fan X
J Exp Clin Cancer Res; 2019 Dec; 38(1):498. PubMed ID: 31856871
[TBL] [Abstract][Full Text] [Related]
52. Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells.
Neri F; Incarnato D; Krepelova A; Rapelli S; Pagnani A; Zecchina R; Parlato C; Oliviero S
Genome Biol; 2013 Aug; 14(8):R91. PubMed ID: 23987249
[TBL] [Abstract][Full Text] [Related]
53. Loss of the polycomb mark from bivalent promoters leads to activation of cancer-promoting genes in colorectal tumors.
Hahn MA; Li AX; Wu X; Yang R; Drew DA; Rosenberg DW; Pfeifer GP
Cancer Res; 2014 Jul; 74(13):3617-3629. PubMed ID: 24786786
[TBL] [Abstract][Full Text] [Related]
54. Genome-wide analysis of bivalent histone modifications during Drosophila embryogenesis.
Cheng Q; Xie H
Genesis; 2022 Dec; 60(10-12):e23502. PubMed ID: 36125264
[TBL] [Abstract][Full Text] [Related]
55. Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma.
Yu Y; Zeng Y; Xia X; Zhou JG; Cao F
Cancer Control; 2021; 28():10732748211033751. PubMed ID: 34569303
[TBL] [Abstract][Full Text] [Related]
56. Bivalent chromatin marks developmental regulatory genes in the mouse embryonic germline in vivo.
Sachs M; Onodera C; Blaschke K; Ebata KT; Song JS; Ramalho-Santos M
Cell Rep; 2013 Jun; 3(6):1777-84. PubMed ID: 23727241
[TBL] [Abstract][Full Text] [Related]
57. Cold stress induces enhanced chromatin accessibility and bivalent histone modifications H3K4me3 and H3K27me3 of active genes in potato.
Zeng Z; Zhang W; Marand AP; Zhu B; Buell CR; Jiang J
Genome Biol; 2019 Jun; 20(1):123. PubMed ID: 31208436
[TBL] [Abstract][Full Text] [Related]
58. Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.
Liu C; Liu L; Chen X; Shen J; Shan J; Xu Y; Yang Z; Wu L; Xia F; Bie P; Cui Y; Bian XW; Qian C
PLoS One; 2013; 8(5):e62828. PubMed ID: 23671639
[TBL] [Abstract][Full Text] [Related]
59. Integrating 5-hydroxymethylcytosine into the epigenomic landscape of human embryonic stem cells.
Szulwach KE; Li X; Li Y; Song CX; Han JW; Kim S; Namburi S; Hermetz K; Kim JJ; Rudd MK; Yoon YS; Ren B; He C; Jin P
PLoS Genet; 2011 Jun; 7(6):e1002154. PubMed ID: 21731508
[TBL] [Abstract][Full Text] [Related]
60. Bivalent Histone Modifications and Development.
Li F; Wan M; Zhang B; Peng Y; Zhou Y; Pi C; Xu X; Ye L; Zhou X; Zheng L
Curr Stem Cell Res Ther; 2018; 13(2):83-90. PubMed ID: 28117006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
